AI assistant
Sending…
STANDARD BIOTOOLS INC. — Director's Dealing 2013
Jan 4, 2013
32853_dirs_2013-01-04_6b80e807-07f1-44f0-8074-5d3b2449a871.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2013-01-02
Reporting Person: JONES ROBERT C (EVP, RESEARCH & DEVELOPMENT)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-02 | Common Stock | M | 4483 | $4.0828 | Acquired | 4483 | Direct |
| 2013-01-02 | Common Stock | M | 1220 | $4.4461 | Acquired | 5703 | Direct |
| 2013-01-02 | Common Stock | S | 5703 | $14.44 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-02 | Employee Stock Option (Right to Buy) | $4.0828 | M | 4483 | Disposed | 2019-11-17 | Common Stock (4483) | Direct |
| 2013-01-02 | Employee Stock Option (Right to Buy) | $4.4461 | M | 1220 | Disposed | 2018-04-23 | Common Stock (1220) | Direct |
Footnotes
F1: The sales reported by Mr. Jones were effected pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2012.
F2: 61% of the shares subject to the Option vested on December 31, 2009, 25% of the remaining 39% of the shares subject to the Option vested on April 1, 2010 and 1/48th of the remaining 39% of the shares subject to the Option shall vest each month thereafter such that all shares subject to the Option shall be fully vested on April 1, 2013.
F3: The shares subject to the Option fully vested on March 22, 2010.
More from STANDARD BIOTOOLS INC.
M&A Activity
2026
Jun 8
M&A Activity
2026
Jun 8
Regulatory Filings
2026
Jun 5
Board/Management Information
2026
Jun 3
Regulatory Filings
2026
May 29
Board/Management Information
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3